These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35067990)

  • 21. Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database.
    Hurault-Delarue C; Montastruc JL; Beau AB; Lacroix I; Damase-Michel C
    Arch Gynecol Obstet; 2014 Aug; 290(2):263-70. PubMed ID: 24664257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden.
    Pedersen L; Petronis KR; Nørgaard M; Mo J; Frøslev T; Stephansson O; Granath F; Kieler H; Sørensen HT
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):94-102. PubMed ID: 31713302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [First epidemiologic data about phloroglucinol exposure during first trimester of pregnancy].
    Lacroix I; Hurault-Delarue C; Kessler S; Guitard C; Vidal S; Albouy-Cossard C; Montastruc JL; Damase-Michel C
    Gynecol Obstet Fertil; 2011 Dec; 39(12):694-7. PubMed ID: 21855385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal exposure to airborne polychlorinated biphenyls (PCBs) and risk of adverse birth outcomes.
    Kofoed AB; Deen L; Hougaard KS; Petersen KU; Meyer HW; Pedersen EB; Ebbehøj NE; Heitmann BL; Bonde JP; Tøttenborg SS
    Eur J Epidemiol; 2021 Aug; 36(8):861-872. PubMed ID: 34420151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical treatment of vaginal candidosis with sertaconazole and econazole sustained-release suppositories.
    Dellenbach P; Thomas JL; Guerin V; Ochsenbein E; Contet-Audonneau N
    Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S47-52. PubMed ID: 11118564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis.
    Sharma A; Saple DG; Surjushe A; Rao GR; Kura M; Ghosh S; Bolmall C; Baliga V
    Mycoses; 2011 May; 54(3):217-22. PubMed ID: 19925567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Maternal Opioid Use in Pregnancy With Adverse Perinatal Outcomes in Ontario, Canada, From 2012 to 2018.
    Corsi DJ; Hsu H; Fell DB; Wen SW; Walker M
    JAMA Netw Open; 2020 Jul; 3(7):e208256. PubMed ID: 32725246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of major congenital malformations following first-trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population-based retrospective cohort study.
    Rotem R; Fishman B; Daniel S; Koren G; Lunenfeld E; Levy A
    BJOG; 2018 Nov; 125(12):1550-1556. PubMed ID: 29790255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis.
    Carrillo-Muñoz AJ; Tur-Tur C; Giusiano G; Marcos-Arias C; Eraso E; Jauregizar N; Quindós G
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):347-58. PubMed ID: 23566144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ophthalmic Corticosteroids in Pregnant Women with Allergic Conjunctivitis and Adverse Neonatal Outcomes: Propensity Score Analyses.
    Hashimoto Y; Michihata N; Yamana H; Shigemi D; Morita K; Matsui H; Yasunaga H; Aihara M
    Am J Ophthalmol; 2020 Dec; 220():91-101. PubMed ID: 32681904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymptomatic vaginal Candida colonization and adverse pregnancy outcomes including preterm birth: a systematic review and meta-analysis.
    Schuster HJ; de Jonghe BA; Limpens J; Budding AE; Painter RC
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100163. PubMed ID: 33345884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: A population-based study.
    Sujan AC; Quinn PD; Rickert ME; Wiggs KK; Lichtenstein P; Larsson H; Almqvist C; Öberg AS; D'Onofrio BM
    PLoS Med; 2019 Dec; 16(12):e1002980. PubMed ID: 31790390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
    Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
    Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perinatal Outcomes After Statin Exposure During Pregnancy.
    Chang JC; Chen YJ; Chen IC; Lin WS; Chen YM; Lin CH
    JAMA Netw Open; 2021 Dec; 4(12):e2141321. PubMed ID: 34967881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
    Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
    BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis.
    Buawangpong N; Teekachunhatean S; Koonrungsesomboon N
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00644. PubMed ID: 32815286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of antifungal activity of sertaconazole, terbinafine, and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes.
    Carillo-Muñoz AJ; Tur-Tur C
    Chemotherapy; 1997; 43(6):387-92. PubMed ID: 9395851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.